Clinical pharmacology study to evaluate the pharmacokinetics, safety and efficacy of multi-targetted tyrosine kinase inhibitor regorafenib in Japanese patients with advanced colorectal cancer.
收藏NIAID Data Ecosystem2026-03-08 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2629287
下载链接
链接失效反馈官方服务：
资源简介：
Primary outcome(s): pharmacokinetics, progression free survival, response rate, adverse event,
创建时间：
2013-12-15
